Cargando…

Prognostic Significance of p53 and ras Gene Abnormalities in Lung Adenocarcinoma Patients with Stage I Disease after Curative Resection

We investigated the prognostic significance of p53 gene abnormalities and ras gene mutations in patients with curatively resected stage I lung adenocarciiioma. Formalin‐fixed and paraffin‐embedded tissues were obtained from 30 patients who had undergone curative resection for stage I lung adenocarci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Isobe, Takeshi, Hiyama, Keiko, Yoshida, Yasuhiro, Fujiwara, Yasuhiro, Yamakido, Michio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1994
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919395/ https://www.ncbi.nlm.nih.gov/pubmed/7852188 http://dx.doi.org/10.1111/j.1349-7006.1994.tb02936.x

Ejemplares similares

Differential Expression of DNA Topoisomerase IIα and IIβ Genes between Small Cell and Non‐small Cell Lung Cancer
por: Syahruddin, Elisna, et al.
Publicado: (1998)

Specific Growth Inhibition of Small‐cell Lung Cancer Cells by Adenovirus Vector Expressing Antisense c‐kit Transcripts
por: Yamanishi, Yuji, et al.
Publicado: (1996)

Phase I Study and Clinical Pharmacological Evaluation of Daily Oral Etoposide Combined with Carboplatin in Patients with Lung Cancer
por: Ohune, Terumasa, et al.
Publicado: (1995)

No Alteration in DNA Topoisomerase I Gene Related to CPT‐11 Resistance in Human Lung Cancer
por: Ohashi, Nobuyuki, et al.
Publicado: (1996)

Multi‐institutional analysis of the prognostic significance of postoperative complications after curative resection for gastric cancer
por: Kanda, Mitsuro, et al.
Publicado: (2019)

The Role of Glucuronidation in 7‐Ethyl‐10‐hydroxycamptothecin Resistance in vitro
por: Takahashi, Toshiaki, et al.
Publicado: (1997)

Cyclooxygenase‐2 (COX‐2) mRNA Expression Levels in Normal Lung Tissues and Non‐small Cell Lung Cancers
por: Ochiai, Mari, et al.
Publicado: (1999)

Differential Expression of Facilitative Glucose Transporter (GLUT) Genes in Primary Lung Cancers and Their Liver Metastases
por: Kurata, Takayasu, et al.
Publicado: (1999)

Determinants of Drug Response in a Cisplatin‐resistant Human Lung Cancer Cell Line
por: Fujiwara, Yasuhiro, et al.
Publicado: (1990)

Survival after curative resection for stage I colorectal mucinous adenocarcinoma
por: Huang, Liang, et al.
Publicado: (2022)

Surveillance and outcomes after curative resection for gastroesophageal adenocarcinoma
por: Jiang, Di M., et al.
Publicado: (2020)

Peristomal adenocarcinoma 16 years after colorectal adenocarcinoma resection with curative intent
por: van Dam, Kayleigh A M, et al.
Publicado: (2023)

Prognostic Significance of Immunohistochemical Expression of p53 and Retinoblastoma Gene Protein (pRB) in Curatively Resected Gastric Cancer
por: Song, Hong Suk, et al.
Publicado: (2005)

Prognostic significance of IMMT expression in surgically‐resected lung adenocarcinoma
por: Hiyoshi, Yasuhiro, et al.
Publicado: (2019)

Expression of gamma-glutamylcysteine synthetase (gamma-GCS) and multidrug resistance-associated protein (MRP), but not human canalicular multispecific organic anion transporter (cMOAT), genes correlates with exposure of human lung cancers to platinum drugs.
por: Oguri, T., et al.
Publicado: (1998)

Enhancement of Tumor Radio‐response by Irinotecan in Human Lung Tumor Xenografts
por: Tamura, Kenji, et al.
Publicado: (1997)

Downregulation of GPR155 as a prognostic factor after curative resection of hepatocellular carcinoma
por: Umeda, Shinichi, et al.
Publicado: (2017)

Former poison gas workers and cancer: incidence and inhibition of tumor formation by treatment with biological response modifier N-CWS.
por: Yamakido, M, et al.
Publicado: (1996)

Haemoptysis as a prognostic factor in lung adenocarcinoma after curative resection
por: Hu, P, et al.
Publicado: (2013)

Fibroblasts as a Biological Marker for Curative Resection in Pancreatic Ductal Adenocarcinoma
por: Katsuta, Eriko, et al.
Publicado: (2020)

Health-related quality of life after curative resection for gastric adenocarcinoma
por: Grosek, Jan, et al.
Publicado: (2021)

Intraoperative peritoneal lavage cytology offers prognostic significance for gastric cancer patients with curative resection
por: Higaki, Eiji, et al.
Publicado: (2017)

Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer
por: Hadano, Naoto, et al.
Publicado: (2016)

Lymph Node Metastasis of Mixed Adenoneuroendocrine Carcinoma after Curative Resection Using the Expanded Criteria for Early Gastric Cancer
por: Ochiai, Tadashi, et al.
Publicado: (2018)

Predictive risk factors for early recurrence in patients with localized pancreatic ductal adenocarcinoma who underwent curative-intent resection after preoperative chemoradiotherapy
por: Murata, Yasuhiro, et al.
Publicado: (2022)

Surgery with curative intent for stage IV gastric cancer: Is it a reality of illusion?
por: Kodera, Yasuhiro
Publicado: (2018)

Gastric Adenocarcinoma with Thymic Metastasis after Curative Resection: A Case Report
por: Matsunaga, Tomoyuki, et al.
Publicado: (2014)

Adenocarcinoma of the ampulla of Vater: predictors of survival and recurrence after curative radical resection
por: Kim, Kang Jae, et al.
Publicado: (2011)

Risk factors and patterns of recurrence after curative resection in Gastroesophageal Junction Adenocarcinoma
por: Batool, Sadaf, et al.
Publicado: (2019)

Prognostic Significance of RAS Mutations and P53 Expression in Cutaneous Squamous Cell Carcinomas
por: Campos, Manuel António, et al.
Publicado: (2020)

Prognostic significance of postoperative pneumonia after curative resection for patients with gastric cancer
por: Tu, Ru‐Hong, et al.
Publicado: (2017)

Cost-effectiveness of adjuvant chemotherapy with uracil–tegafur for curatively resected stage III rectal cancer
por: Hisashige, A, et al.
Publicado: (2008)

Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer
por: Schneider, P M, et al.
Publicado: (2000)

Survival times are similar among patients with peritoneal, hematogenous, and nodal recurrences after curative resections for gastric cancer
por: Sawaki, Koichi, et al.
Publicado: (2020)

Evaluation of K-ras and p53 expression in pancreatic adenocarcinoma using the cancer genome atlas
por: Lu, Liming, et al.
Publicado: (2017)

Biomarkers as Predictors of Recurrence following Curative Resection for Pancreatic Ductal Adenocarcinoma: A Review
por: Osayi, Sylvester N., et al.
Publicado: (2014)

The impact of SPARC expression on the survival of pancreatic ductal adenocarcinoma patients after curative resection
por: Murakawa, Masaaki, et al.
Publicado: (2019)

Percutaneous Radiofrequency Ablation for Metachronous Hepatic Metastases after Curative Resection of Pancreatic Adenocarcinoma
por: Lee, So Jung, et al.
Publicado: (2020)

Advanced Colon Cancer after Curative Resection of Intramucosal Adenocarcinoma with Endoscopic Submucosal Dissection
por: Sasaki, Akiko, et al.
Publicado: (2021)

The Association and Significance of p53 in Gynecologic Cancers: The Potential of Targeted Therapy
por: Nakamura, Mitsuhiro, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lnhseuddmi1b2pt7kkaojfops1